Riskpilot← Back to searchSign inGet full accessAPOTEK MORENEN AS
ASActiveOrg 992983426Morenen Kjøpesenter Morstongveien 47, 1859 SlituRetail sale of pharmaceutical products · NACE 4773Est. 20085 employeeswww.vitusapotek.no
Revenue 2024
NOK 12,2M
+21% vs 2023
EBITDA margin
20.2%
+298% vs 2023
Equity ratio
8.7%
Financial strength
Net profit 2024
NOK 1,9M
+290% vs 2023
| Revenue | NOK 12,2M | +21% |
| EBITDA | NOK 2,5M | +298% |
| Net profit | NOK 1,9M | +290% |
| Total assets | NOK 7,7M | +343% |
| Equity | NOK 665K | -8% |
| Employees | 5 | — |
Legal name
APOTEK MORENEN AS
Org number
992983426
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
1. september 2008
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av legemidler, helsepleieartikler, kroppspleieartikler og relaterte produkter til publikum, helsevesen og øvrig næringsliv i eidsberg og omliggende kommuner fra fast utsalgssted.
Address
Morenen Kjøpesenter Morstongveien 47, 1859 Slitu
Phone
+4769890880
Email
morenen@apotekmail.com
Website
www.vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 889 | 18 228 | 18 541 | 10 066 | 12 160 |
| Staff expenses | −1 551 | −1 632 | −1 664 | −1 562 | −1 141 |
| EBITDA | 2 487 | 2 495 | 2 153 | 616 | 2 451 |
| Depreciation & amort. | −4 | −0 | −0 | −0 | −24 |
| EBIT | 2 483 | 2 495 | 2 153 | 616 | 2 427 |
| Net financials | 6 | −1 | 8 | 19 | 58 |
| Profit before tax | 2 489 | 2 493 | 2 161 | 636 | 2 486 |
| Tax | 543 | 544 | 472 | 137 | 543 |
| Net profit | 1 946 | 1 949 | 1 689 | 498 | 1 943 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 472 | 10 607 | 10 757 | 1 727 | 7 661 |
| Equity | 3 853 | 5 802 | 224 | 722 | 665 |
| Long-term debt | 0 | 0 | 2 | 0 | 0 |
| Short-term debt | 4 619 | 4 805 | 10 531 | 1 005 | 6 996 |
| Total debt | 4 619 | 4 805 | 10 533 | 1 005 | 6 996 |
EBITDA margin
20.2%
This company
15.8%
Market median
+28% vs market
20202024
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
20202024
Return on equity
292.1%
This company
18.4%
Market median
+1488% vs market
20202024
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20202024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20202024
Debt / equity
10.52×
This company
0.62×
Market median
-1597% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EN Deputy Member | Deputy Member | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Deputy Chairman | 2021 | |
| Deputy Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oslo Pharma Invest As
APOTEK MORENEN AS Board members of APOTEK MORENEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Næristorp | Deputy Member | 0 companies |
| Johnny Ng | Chairman | 0 companies |
| Linda Solheim | Deputy Chairman | 0 companies |
| Lee Solheim | Deputy Chairman | 0 companies |